Global PCR-Based Transplant Diagnostics Market - Industry Trends and Forecast to 2031
Global PCR based transplant diagnostics market is expected to reach USD 995,007.52 thousand by 2031, from USD 612,500.00 thousand in 2023 growing at the CAGR of 6.5% in the forecast period of 2024 to 2031.
Market SegmentationGlobal PCR based Transplant diagnostics Market, By Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR TestHSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), By Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest Of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa )– Industry Trends and Forecast to 2031
Overview of Global PCR Based Transplant Diagnostics Market Dynamics
Driver• Increasing prevalence of organ failure
Restraint • Shortage of professionals with expertise in transplant diagnostics
Opportunity • Strategic initiation and technology launches by market players
Market PlayersSome of the major market players for the global PCR based transplant diagnostics market are: • Quest Diagnostics Incorporated.
• Laboratory Corporation of America Holdings.
• Eurofins Viracor, LLC
• Sonic Healthcare USA
• Dr Lal PathLabs
• ARUP Laboratories.
• Amber Lab